---
provider: claude_code
model: claude-haiku-5-5, claude-opus-5-5
cached: false
start_time: '2026-10-30T21:31:16.963589'
end_time: '2026-10-30T21:34:41.906356'
duration_seconds: 204.94
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: VIBCH
  gene_id: VC_0072
  gene_symbol: VC_0072
  uniprot_accession: Q9KVR7
  protein_description: 'SubName: Full=Sensory box/GGDEF family protein {ECO:0000313|EMBL:AAF93250.1};'
  gene_info: OrderedLocusNames=VC_0072 {ECO:0000313|EMBL:AAF93250.1};
  organism_full: Vibrio cholerae serotype O1 (strain ATCC 39315 / El Tor Inaba N16961).
  protein_family: Not specified in UniProt
  protein_domains: Biofilm_reg_signaling. (IPR052155); EAL_dom. (IPR001633); EAL_sf.
    (IPR035919); GGDEF_dom. (IPR000160); Nucleotide_cyclase. (IPR029787)
provider_config:
  timeout: 1800
  max_retries: 3
  parameters:
    allowed_domains: []
    claude_executable: claude
    skip_permissions: false
    allowed_tools:
    - WebSearch
    - WebFetch
    add_dirs: []
    timeout: 1800
    min_report_chars: 200
    extra_args: []
run_metadata:
  models_used:
  - claude-haiku-5-5
  - claude-opus-5-5
  web_search_requests: 3
  num_turns: 9
  total_cost_usd: 0.8131281500000003
  session_id: a2fa75ed-54e0-48a5-8d9d-c21aecb17e84
  stop_reason: end_turn
  assistant_text_blocks: 1
citation_count: 13
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q9KVR7
- **Protein Description:** SubName: Full=Sensory box/GGDEF family protein {ECO:0000313|EMBL:AAF93250.1};
- **Gene Information:** OrderedLocusNames=VC_0072 {ECO:0000313|EMBL:AAF93250.1};
- **Organism (full):** Vibrio cholerae serotype O1 (strain ATCC 39315 / El Tor Inaba N16961).
- **Protein Family:** Not specified in UniProt
- **Key Domains:** Biofilm_reg_signaling. (IPR052155); EAL_dom. (IPR001633); EAL_sf. (IPR035919); GGDEF_dom. (IPR000160); Nucleotide_cyclase. (IPR029787)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "VC_0072" matches the protein description above**
2. **Verify the organism is correct:** Vibrio cholerae serotype O1 (strain ATCC 39315 / El Tor Inaba N16961).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'VC_0072' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **VC_0072** (gene ID: VC_0072, UniProt: Q9KVR7) in VIBCH.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

# VC_0072 (UniProt Q9KVR7), *Vibrio cholerae* O1 El Tor N16961: a membrane-anchored PAS–GGDEF–EAL c-di-GMP signalling protein

## 1. Identity check

| Item | Value | Matches the target? |
|---|---|---|
| Locus tag | VC_0072 (VC0072), EMBL AAF93250.1, chromosome I | Yes |
| Organism | *V. cholerae* serotype O1, strain N16961 (taxon 243277) | Yes |
| UniProt name | "Sensory box/GGDEF family protein" (submitter-imported; unreviewed, PE 4: Predicted) | Yes |
| Length | 768 aa, 88.1 kDa | — |
| Domains | PAS (214–269; SMART counts 2 PAS), GGDEF (368–501), EAL (512–767); CDD cd00130, cd01949, cd01948 | Yes |
| Family | PANTHER PTHR44757 (diguanylate cyclase DgcP), subfamily SF4 (DgcE-related); InterPro IPR052155 Biofilm_reg_signaling | Yes |

The locus tag is unambiguous. Every literature hit below names VC0072 as a GGDEF + EAL protein, which agrees with the UniProt domain annotation, so no papers about a different gene were mixed in. Published work on this specific protein is very limited. Much of what follows is therefore inferred from its sequence and domains, and each claim says which kind of evidence it rests on.

## 2. Summary

VC_0072 is one of the roughly ten *V. cholerae* proteins that carry both a GGDEF (diguanylate cyclase, DGC) domain and an EAL (c-di-GMP phosphodiesterase, PDE) domain.

- **Location (inferred):** it is predicted to sit in the inner membrane, with its PAS sensory domain and both catalytic domains on the cytoplasmic side.
- **Catalytic sites (inferred):** both domains keep their catalytic motifs, so the protein may make c-di-GMP from two GTP (DGC, EC 2.7.7.65) and/or break it down to pApG (PDE-A, EC 3.1.4.52).
- **Binding (shown experimentally):** a genome-wide screen found that the purified protein binds c-di-GMP specifically. Because it lacks the RxxD inhibitory site (I-site), the authors proposed that the binding happens at the EAL domain ([Roelofs et al., 2015, *PLoS Pathog* 11:e1005232; PMID 26506097](https://pmc.ncbi.nlm.nih.gov/articles/PMC4624772/)).
- **Untested:** whether it actually makes or degrades c-di-GMP, and what it does to biofilm or motility, has not been reported in any source I could read.

## 3. Sequence and domain analysis (my own analysis of the UniProt sequence)

### 3.1 N-terminal membrane anchor and likely topology
- **Lipobox (predicted):** PROSITE PS51257 predicts a cleavable lipoprotein signal peptide (residues 1–24) with N-palmitoyl/S-diacylglycerol Cys25 (motif "LGC↓"). This is a rule-based prediction only (PRU00303).
- **Transmembrane helix (predicted):** Phobius predicts a helix at residues 57–79 (ECO:0000256|SAM:Phobius).
- **Most likely topology:** two N-terminal hydrophobic segments (the 1–24 segment acting as a signal or transmembrane anchor, plus TM 57–79). That gives a short periplasmic loop of about 30 residues and a large cytoplasmic part (residues ~80–768) holding the PAS, GGDEF and EAL domains. This is the usual layout of membrane-bound c-di-GMP enzymes such as *E. coli* DgcE and *V. cholerae* MbaA.
- **Lipoprotein call is doubtful:** a periplasmic lipoprotein with a downstream TM helix and cytoplasmic catalytic domains would be topologically incoherent, and the catalytic domains need cytoplasmic GTP.
- **GOA:** the plasma-membrane location is consistent with the existing IBA annotation, GO:0005886.

### 3.2 PAS sensor domain(s)
- **Domain calls:** PAS_9 (Pfam PF13426), PROSITE PS50112 at 214–269, and SMART SM00091 ×2, which indicates a second, less canonical PAS repeat around 100–210.
- **Likely role:** in GGDEF/EAL proteins, PAS domains usually sense signals such as O₂, redox state or small ligands, or mediate dimerization. They control which catalytic output dominates.
- **Unknown:** no ligand has been identified for VC_0072's PAS domain.

### 3.3 GGDEF domain (DGC): catalytic motifs intact

| Feature | VC_0072 | Canonical | Interpretation |
|---|---|---|---|
| Metal-binding D | "LYL**D**LD" (~D388) | DxLD | intact |
| GTP-binding loop | "N**D**TA**GH**DA**GD**" | NDxxGHxxGD | intact |
| A-site | **GGDEF** at 417–421 | GG(D/E)EF | intact |
| I-site (RxxD) | absent | RxxD ~5–10 aa from A-site | no allosteric product inhibition |

- **Active site:** the A-site and the conserved β-hairpin and metal-binding residues are intact, so a functional DGC is predicted.
- **Caveat:** many GGDEF–EAL proteins with intact GGDEF motifs work mainly as PDEs, or use the GGDEF domain to regulate the EAL domain. Examples are *Caulobacter* CC3396 and *Pseudomonas* RbdA and MorA.
- **Missing I-site:** Roelofs et al. independently noted this: "Four ORFs (VC0072, VC0658, VC0703 (MbaA), VC1934) were identified with both GGDEF and EAL domains, but lacking the RxxD motif, suggesting that c-di-GMP binding occurs at the EAL domain" ([PMID 26506097](https://pmc.ncbi.nlm.nih.gov/articles/PMC4624772/)).

### 3.4 EAL domain (PDE-A): one conservative substitution
- **Signature motif:** "LHF**EVL**VR" (E547-V548-L549) replaces the canonical EAL. EVL is a conservative change that is often found in active EAL PDEs.
- **Other catalytic residues match the canonical EAL PDE set** (as defined for TBD1265, RocR, BlrP1 and others):
  - "INLSGN": the catalytic N/Q loop
  - "EITE": the metal-coordinating E
  - **DDFGSG** (668–673): the DDFGTG loop, with a conservative S for T
  - "VKIDGIF": the catalytic K and metal-binding D (loop 6 region)
  - "VAE**FVE**N": the general base E in the "AEGVE" motif
  - "QGYLFSRP": the QGYxxxRP dimerization/loop motif
- **Overall:** the EAL domain looks fully competent to hydrolyze c-di-GMP to 5′-pGpG in a Mg²⁺/Mn²⁺-dependent reaction (my sequence inference; not tested biochemically).
- **Context:** CdgC (VC0658), the best-characterized close relative in the same genome with a GGDEF–EAL layout, has an active EAL domain and a predicted inactive GGDEF domain ([Lim et al., 2007, *J Bacteriol* 189:717](https://journals.asm.org/doi/10.1128/jb.00834-06)).

## 4. Experimental evidence specific to VC_0072

### 4.1 c-di-GMP binding (DRaCALA): positive

Roelofs et al. (2015; Lee and Yildiz labs) expressed nearly all *V. cholerae* ORFs as His and His-MBP fusions and screened them for ³²P-c-di-GMP binding by DRaCALA ([PLoS Pathog 11:e1005232, Oct 2015; PMID 26506097](https://pmc.ncbi.nlm.nih.gov/articles/PMC4624772/)).

**Table 1 results for VC0072** (fraction of ³²P-c-di-GMP bound, by competitor):

| Construct | No competitor | Unlabeled c-di-GMP | cGMP | GTP |
|---|---|---|---|---|
| His-ORF | 0.36 | 0.00* | 0.49 | 0.48 |
| His-MBP-ORF | 0.47 | 0.02* | 0.51 | 0.55 |

\* p < 0.001 (two-way ANOVA against no competitor).

- **Specificity:** only unlabeled c-di-GMP competed binding away; cGMP and GTP did not. So the binding is specific for c-di-GMP.
- **Classification:** Table 2 lists VC0072 under "EAL" as "Predicted | Positive", meaning a predicted binder that was experimentally confirmed.
- **Interpretation:** binding without an I-site fits substrate binding at the EAL active site. That supports, but does not prove, PDE activity. A substrate-binding EAL domain can be either catalytic or a degenerate receptor; in VC_0072 the catalytic residues are intact (section 3.4).

### 4.2 Systematic phenotypic screens
- **Hunter et al. 2014:** this study of the degenerate DGC VCA0965 tested all predicted *V. cholerae* DGCs for whether overexpressing them inhibits swimming motility. VC0072 appears among the tested GGDEF proteins in a figure ([Hunter et al., 2014, *BMC Microbiol* 14:22](https://bmcmicrobiol.biomedcentral.com/track/pdf/10.1186/1471-2180-14-22); [PMC version](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974145/)). I could not get the full text, so I cannot report VC0072's specific result.
- **Biofilm deletion screen:** a 2010 Yildiz-lab screen deleted every GGDEF/EAL gene and looked for effects on biofilm and *vps* expression. It identified CdgJ (VC0137) as the gene whose loss affected these; VC0072 was not singled out ([Liu et al., 2010, *J Bacteriol*](https://journals.asm.org/doi/full/10.1128/jb.00209-10)).
- **Larger profiling efforts:** later studies of all ~53 c-di-GMP modulators (including a 2024 bioRxiv preprint, [doi 10.1101/2024.09.01.610008](https://www.biorxiv.org/content/10.1101/2024.09.01.610008.full.pdf)) list VC0072. I could not get its specific data (the server rate-limited my access).
- **Bottom line:** no published experiment I could verify assigns VC_0072 a measured DGC or PDE activity, a change in cellular c-di-GMP, or a biofilm or motility phenotype.

## 5. Pathway context: the *V. cholerae* c-di-GMP network

- **Network size:** the genome encodes roughly 31 GGDEF-only, 12 EAL-only, 10 GGDEF–EAL and 9 HD-GYP proteins. This is one of the largest c-di-GMP networks studied, as summarized in [Hunter et al. 2014](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974145/) and [Tischler & Camilli, 2005, *Infect Immun*](https://journals.asm.org/doi/10.1128/iai.73.9.5873-5882.2005).
- **High c-di-GMP effects:**
  - It activates *vps* (Vibrio polysaccharide) gene expression through VpsR and VpsT, causing rugose colonies and biofilm ([Beyhan et al., 2006, *Mol Microbiol*](https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2958.2006.05106.x)).
  - It promotes MSHA pilus extension and surface attachment through the MshE ATPase receptor ([Floyd et al., 2020, *Nat Commun*](https://www.nature.com/articles/s41467-020-15331-8); [Jones et al., 2015, *PLoS Pathog*](https://journals.plos.org/plospathogens/article?id=10.1371%2Fjournal.ppat.1005068)).
  - It induces type II secretion ([Sloup et al., 2017, *J Bacteriol*](https://journals.asm.org/doi/10.1128/jb.00106-17)).
  - It represses FlrA-dependent flagellar gene transcription and motility ([Srivastava et al., 2013, *Mol Microbiol*; PMID 24134710](https://pmc.ncbi.nlm.nih.gov/articles/PMC3881292/)).
  - It positively regulates DNA repair ([Fernandez et al., 2018, *J Bacteriol*](https://journals.asm.org/doi/10.1128/jb.00005-18)).
- **Low c-di-GMP effects:** motility and virulence gene expression (*toxT*, *ctx*, *tcp*) are favoured ([Tischler & Camilli 2005](https://journals.asm.org/doi/10.1128/iai.73.9.5873-5882.2005)).
- **Where VC_0072 fits:** as a membrane-anchored, PAS-regulated GGDEF–EAL protein, it most likely acts as a signal-responsive local source or sink of c-di-GMP. In that role it would feed into one or more of these outputs, probably locally ("high-specificity" signalling, as described for *V. cholerae* DGCs). Which output it controls is unknown.

## 6. Existing GO annotations

All three current GOA rows are IBA (PAINT, family PTHR44757):

| GO term | Assessment |
|---|---|
| GO:0005886 plasma membrane (is_active_in) | Well supported by the predicted TM helix and lipobox, and fits the cytoplasmic-facing catalytic domains. The inner (cytoplasmic) membrane is the expected compartment. |
| GO:0071111 cyclic-guanylate-specific phosphodiesterase activity (enables) | Plausible: the EAL catalytic residues are intact (DDFGSG, EVL, conserved K/E/N) and specific c-di-GMP binding has been shown ([PMID 26506097](https://pmc.ncbi.nlm.nih.gov/articles/PMC4624772/)). Activity has not been tested directly. |
| GO:1900190 regulation of single-species biofilm formation (involved_in) | Plausible at the family level, but no VC_0072-specific phenotype has been reported. |

- **Not in GOA:** diguanylate cyclase activity (GO:0052621) has no row, although the GGDEF site is intact. Whether to add it is an open question rather than a confirmed function.
- **Supported by experiment:** "cyclic-di-GMP binding" (GO:0035438) is backed by the DRaCALA data.

## 7. Open questions and suggested experiments

1. **Which activity dominates?** Purify the cytoplasmic region (~80–768) and assay it with GTP (DGC) and with c-di-GMP (PDE). Test the GGDEF→GGAAF and EVL→AAA (or E547A) mutants.
2. **What does the PAS domain sense?** Screen for heme or flavin cofactors and test effects of O₂ or redox state. Ask whether the periplasmic loop senses an external signal.
3. **What does it do in vivo?** Examine a ΔVC_0072 mutant and an overexpression strain for c-di-GMP levels (by LC-MS/MS), *vps* reporter activity, biofilm, motility and MSHA pilus dynamics. Do this in both the high-c-di-GMP (rugose) and the wild-type backgrounds.
4. **Topology:** test the lipoprotein vs. two-TM model with PhoA/LacZ fusions.

## 8. Confidence

| Claim | Evidence | Confidence |
|---|---|---|
| PAS–GGDEF–EAL layout | InterPro/Pfam/SMART/CDD | High |
| Inner-membrane anchored, catalytic domains in the cytoplasm | Phobius TM + lipobox prediction; family analogy | Medium–High |
| Specific c-di-GMP binding | DRaCALA, competition by c-di-GMP only ([PMID 26506097](https://pmc.ncbi.nlm.nih.gov/articles/PMC4624772/)) | High (in vitro) |
| c-di-GMP PDE activity (EAL) | Intact catalytic residues + substrate binding | Medium (inferred) |
| DGC activity (GGDEF) | Intact GGDEF and metal/GTP-binding motifs; no I-site | Low–Medium (inferred; could be regulatory) |
| Role in biofilm/motility regulation | Family-level inference only | Low–Medium |

## Sources
- UniProt Q9KVR7 entry and GOA file (local: `genes/VIBCH/VC_0072/VC_0072-uniprot.txt`, `VC_0072-goa.tsv`)
- [Roelofs KG et al. 2015. Systematic identification of cyclic-di-GMP binding proteins in *Vibrio cholerae*… PLoS Pathog 11:e1005232. PMID 26506097](https://pmc.ncbi.nlm.nih.gov/articles/PMC4624772/)
- [Hunter JL et al. 2014. The *V. cholerae* diguanylate cyclase VCA0965 has an AGDEF active site and synthesizes cyclic di-GMP. BMC Microbiol 14:22](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974145/) ([PDF](https://bmcmicrobiol.biomedcentral.com/track/pdf/10.1186/1471-2180-14-22))
- [Lim B et al. 2007. Regulation of VPS synthesis and virulence factor production by CdgC, a GGDEF-EAL domain protein. J Bacteriol](https://journals.asm.org/doi/10.1128/jb.00834-06)
- [Liu X et al. 2010. Identification and characterization of a phosphodiesterase that inversely regulates motility and biofilm formation in *V. cholerae*. J Bacteriol](https://journals.asm.org/doi/full/10.1128/jb.00209-10)
- [Beyhan S et al. 2006. Cyclic-diGMP signal transduction systems in *V. cholerae*: modulation of rugosity and biofilm formation. Mol Microbiol](https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2958.2006.05106.x)
- [Tischler AD, Camilli A. 2005. Cyclic diguanylate regulates *V. cholerae* virulence gene expression. Infect Immun](https://journals.asm.org/doi/10.1128/iai.73.9.5873-5882.2005)
- [Srivastava D et al. 2013. Cyclic di-GMP inhibits *V. cholerae* motility… Mol Microbiol. PMID 24134710](https://pmc.ncbi.nlm.nih.gov/articles/PMC3881292/)
- [Floyd KA et al. 2020. c-di-GMP modulates type IV MSHA pilus retraction and surface attachment. Nat Commun](https://www.nature.com/articles/s41467-020-15331-8)
- [Jones CJ et al. 2015. C-di-GMP regulates motile to sessile transition by modulating MshA pili biogenesis. PLoS Pathog](https://journals.plos.org/plospathogens/article?id=10.1371%2Fjournal.ppat.1005068)
- [Sloup RE et al. 2017. Cyclic di-GMP and VpsR induce the expression of type II secretion in *V. cholerae*. J Bacteriol](https://journals.asm.org/doi/10.1128/jb.00106-17)
- [Fernandez NL et al. 2018. Cyclic di-GMP positively regulates DNA repair in *V. cholerae*. J Bacteriol](https://journals.asm.org/doi/10.1128/jb.00005-18)
- [Negative feedback of cyclic di-GMP levels optimizes switching between sessile and motile lifestyles in *V. cholerae* (bioRxiv 2024)](https://www.biorxiv.org/content/10.1101/2024.09.01.610008.full.pdf) (full text not accessed)

## Citations

1. https://pmc.ncbi.nlm.nih.gov/articles/PMC4624772/
2. https://journals.asm.org/doi/10.1128/jb.00834-06
3. https://bmcmicrobiol.biomedcentral.com/track/pdf/10.1186/1471-2180-14-22
4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974145/
5. https://journals.asm.org/doi/full/10.1128/jb.00209-10
6. https://www.biorxiv.org/content/10.1101/2024.09.01.610008.full.pdf
7. https://journals.asm.org/doi/10.1128/iai.73.9.5873-5882.2005
8. https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2958.2006.05106.x
9. https://www.nature.com/articles/s41467-020-15331-8
10. https://journals.plos.org/plospathogens/article?id=10.1371%2Fjournal.ppat.1005068
11. https://journals.asm.org/doi/10.1128/jb.00106-17
12. https://pmc.ncbi.nlm.nih.gov/articles/PMC3881292/
13. https://journals.asm.org/doi/10.1128/jb.00005-18